Skip to main content

Table 1 Association between SEPT9 expression and the clinicopathological features of patients with cervical cancer

From: Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance

  

SEPT9 expression

 

Characteristics

Patient

Low

High

P

 

n = 75

n = 16

n = 59

 

Age

 < 50

49

13

36

0.131

 ≥ 50

26

3

23

FIGO stage

 I

50

10

40

0.69

 II

25

6

19

Tumor diameter

 ≤ 4 cm

57

12

45

0.916

 > 4 cm

18

4

14

Differentiation grade

 High

5

1

4

0.94

 Middle+low

70

15

55

Lymph node metastasis

 Positive

22

1

21

0.022*

 Negative

53

15

38

Vasoinvasion

 Yes

20

3

17

0.419

 No

55

13

42

  1. *Significant P values (P < 0.05)